These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17094252)

  • 1. Discovering regulated networks during HIV-1 latency and reactivation.
    Bandyopadhyay S; Kelley R; Ideker T
    Pac Symp Biocomput; 2006; ():354-66. PubMed ID: 17094252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of HIV-1 persistence and evolving strategies for virus eradication.
    Dhamija N; Rawat P; Mitra D
    Subcell Biochem; 2013; 61():479-505. PubMed ID: 23150264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutics for HIV-1 reactivation from latency.
    Sgarbanti M; Battistini A
    Curr Opin Virol; 2013 Aug; 3(4):394-401. PubMed ID: 23810462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 chronic infection is associated with different gene expression in MT-4, H9 and U937 cell lines.
    Olivares I; Ballester A; Lombardia L; Dominguez O; López-Galíndez C
    Virus Res; 2009 Jan; 139(1):22-31. PubMed ID: 19000723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal pathogens and reactivation of latent HIV infection: a review of the literature.
    Jordan L
    J Dent Hyg; 2013 Apr; 87(2):59-63. PubMed ID: 23986138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.
    Duverger A; Wolschendorf F; Anderson JC; Wagner F; Bosque A; Shishido T; Jones J; Planelles V; Willey C; Cron RQ; Kutsch O
    J Virol; 2014 Jan; 88(1):364-76. PubMed ID: 24155393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of HIV-1 latency by chromatin structure and nuclear architecture.
    Lusic M; Giacca M
    J Mol Biol; 2015 Feb; 427(3):688-94. PubMed ID: 25073101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell RNA-Seq Reveals Transcriptional Heterogeneity in Latent and Reactivated HIV-Infected Cells.
    Golumbeanu M; Cristinelli S; Rato S; Munoz M; Cavassini M; Beerenwinkel N; Ciuffi A
    Cell Rep; 2018 Apr; 23(4):942-950. PubMed ID: 29694901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct promoter activation mechanisms modulate noise-driven HIV gene expression.
    Chavali AK; Wong VC; Miller-Jensen K
    Sci Rep; 2015 Dec; 5():17661. PubMed ID: 26666681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous reactivation of latent HIV-1 promoters is linked to the cell cycle as revealed by a genetic-insulators-containing dual-fluorescence HIV-1-based vector.
    Kok YL; Schmutz S; Inderbitzin A; Neumann K; Kelley A; Jörimann L; Shilaih M; Vongrad V; Kouyos RD; Günthard HF; Berens C; Metzner KJ
    Sci Rep; 2018 Jul; 8(1):10204. PubMed ID: 29977044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 and persistent clinical latency, TAR element analysis and improved method for in vitro viral reactivation.
    Lefebvre JC; Durant J; Koechlin A; Rahelinirina V; March D; Lesimple J; Thyss S; Dellamonica P; Cottalorda J
    J Clin Virol; 2007 Apr; 38(4):348-52. PubMed ID: 17339129
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency.
    Wilhelm E; Bell B
    Curr Opin Virol; 2013 Aug; 3(4):380-6. PubMed ID: 23827503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
    Van Lint C; Quivy V; Demonté D; Chariot A; Vanhulle C; de Walque S; Gaudray G; Veithen E; Bours V; Piette J; Burny A
    Bull Mem Acad R Med Belg; 2004; 159(Pt 2):176-89. PubMed ID: 15615091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designed transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.
    Wang X; Wang P; Fu Z; Ji H; Qu X; Zeng H; Zhu X; Deng J; Lu P; Zha S; Song Z; Zhu H
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):98-106. PubMed ID: 25403229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF activation of C/EBPbeta (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages.
    Horie R; Ishida T; Maruyama-Nagai M; Ito K; Watanabe M; Yoneyama A; Higashihara M; Kimura S; Watanabe T
    Microbes Infect; 2007 May; 9(6):721-8. PubMed ID: 17409010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency.
    Wang P; Qu X; Zhou X; Shen Y; Ji H; Fu Z; Deng J; Lu P; Yu W; Lu H; Zhu H
    Virology; 2015 Dec; 486():228-38. PubMed ID: 26469550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid expression of human immunodeficiency virus following activation of latently infected cells.
    Arlen PA; Brooks DG; Gao LY; Vatakis D; Brown HJ; Zack JA
    J Virol; 2006 Feb; 80(3):1599-603. PubMed ID: 16415036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS.
    Huang CB; Alimova YV; Ebersole JL
    Cell Immunol; 2011; 268(2):105-11. PubMed ID: 21420664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral and latent reservoir persistence in HIV-1-infected patients on therapy.
    Kim H; Perelson AS
    PLoS Comput Biol; 2006 Oct; 2(10):e135. PubMed ID: 17040122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.